v" Protection of the brain and spinal cord against ischemia is a goal of vast clinical importance. One approach to this objective is to reduce the tissue's functional activity in order to preserve energy for the metabolic processes that are essential to viability. Experiments to explore ways of reducing function-related energy demands were performed on isolated rabbit retina, a well-characterized model of organized adult mammalian central nervous system (CNS) tissue. The retina was maintained in a nearly physiological state in a miniature "heart-lung" apparatus. Energy metabolism (oxygen consumption and glycolysis) and electrophysiological function (determined by electroretinogram) of the in vitro retina were monitored, and their responses to a series of agents that may reduce energy requirements were determined.
A PPROACHES to preventing cell death due to ischemia generally fall into one of two categories: 1) the supply side; that is, enhancement of circulation, or 2) the demand side; that is, measures to extend cellular viability in the face of diminished circulation. One of the problems in the interpretation of research in this field has been to determine into which category a particular intervention fits: for example, in in vivo experiments, a pharmacological agent may influence cerebral circulation or metabolism, or both.
In order to study specifically the issue of cellular metabolic requirements, we have used an isolated preparation of organized adult mammalian central nervous system (CNS) tissue (rabbit retina) maintained in a miniature heart-lung apparatus. This experimental preparation has allowed us to monitor metabolic parameters (oxygen consumption and glycolysis) as well as electrophysiological function. We have found this system to be relatively simple and highly reproducible, and have used it to screen agents of potential benefit to ischemic CNS cells. Our screening to date has disclosed a number of agents which are promising in that they appear to promote reversible reductions in cellular energy requirements. Some of these data have been presented previously in preliminary form. 4
Materials and Methods
Retinas were isolated from New Zealand White rabbits under darkroom conditions and incubated in the dark in a medium that simulated cerebrospinal fluid (CSF) with respect to electrolytes and 38 organic constituents. This technique has been described in detail elsewhere. 3 A retina was secured over a mandrel in a miniature "heart-lung" apparatus and superfused with medium that had been equilibrated with a gas mixture of 40% 02, 5% CO2, and 55% N2, and that was circulated by a peristaltic p u m p at a rate of 4.6 ml/min. The experiments were performed in a warm room maintained at 37"C. For studies of the effect of temperature itself, the apparatus was immersed in a water bath that permitted temperature to be adjusted over a 15"C range and maintained to within _ 0.2"C. Platinum electrodes incorporated in the apparatus on either side of the retina were used to record the electroretinogram (ERG). Pairs of electrodes sampled the circulating medium to determine 02 and p H before and after it had passed over the retina. The electrodes' signals were conventionally amplified and displayed with a high-speed ink recorder.*
The apparatus was used in two modes for the measurement of 02 consumption and acid production. In one, gas exchange in the "lung" was maintained, and the differences in the outputs of the paired electrodes were measured; these "arteriovenous" differences, multiplied by the flow rate of the medium, gave rates of 02 consumption and acid production. In the other mode, the lung was bypassed so that there was a continuing fall in 02 and p H in the relatively small volume of recirculating fluid (Fig. 1) ; these reductions, multiplied by the volume (2.3 ml), provided an alternative measure of O2 consumption and acid production. The results obtained by the two methods agreed well. The first * Ink recorder manufactured by Gould Inc., Instruments Division, Cleveland, Ohio. method showed the time course of the response to a change in conditions; the second method gave somewhat more reproducible results and was used for most of the studies reported here. Recordings of the electrode responses to known changes in pO2, pCO2, and temperature were obtained in the absence of a retina, in order to calibrate the electrodes and to correct for the effects of temperature and the relatively small m o v e m e n t of 02 and CO2 between the m e d i u m and the walls of the apparatus.
The rate of glycolysis was calculated assuming that the measured reduction in the p H of the m e d i u m as it passed over the tissue was due principally to the generation of CO2 from glucose oxidation and the generation of lactic acid from glycolysis. The generation of CO2 from glucose oxidation was determined from the measurement of 02 consumption. The additional fall in the p H of the bicarbonate-buffered m e d i u m was attributed to lactic acid and served as the basis for calculating its concentration. The concentration of lactic acid (HA) was determined by solving the following equation for HA:
22.6 -HA pHv = 6.1 + log 1.105 + HA + CO2"
In the equation, pHv is the (lowered) p H measured in the "venous" m e d i u m containing the products of retinal metabolism; 6.1 is the p K ' of carbonic acid; 22.6 is the initial concentration (mM) of HCO3 in the medium; I. 105 is the initial concentration (mM) of H2CO3 (and dissolved CO2) with 5% CO2 at 37"C; and CO2 is the additional H2CO3 (and dissolved CO2) generated by the oxidative metabolism of the tissue, as measured by its oxygen consumption. t Althesin is a rapidly acting steroid anesthetic agent which consists of 9 nag ofalphazalone and 3 mg of alphadolone acetate per milliliter. It is available from Glaxo Laboratories Ltd., Greenford, Middlesex, England.
Dose may have been slightly lower due to volatilization of the gas.
Retinas i n c u b a t i n g u n d e r control conditions appeared to be in a physiological state as judged by the stability o f their electrophysiological responses a n d energy m e t a b o l i s m over m a n y hours. Experiments lasted 6 to 12 hours. Usually each agent was introduced for 20 to 70 minutes, following which the retina was returned to control c o n d i t i o n s in order to assess recovery; but, in s o m e e x p e r i m e n t s , the effect o f increasing the dose of the agent was o b s e r v e d before the retina was returned to control c o n d i t i o n s (Fig. 2) . In t e m p e r a t u r e experiments a succession o f reductions (or increases) in t e m p e r a t u r e were tested before returning the retina to the starting t e m p e r a t u r e . I n the one trial o f a six-drug c o m b i n a t i o n (see Fig. 6 ), the agents were i n t r o d u c e d sequentially in the o r d e r shown so that the effects o f each could be m e a s u r e d (each agent had been previously tested individually, a n d o p t i m a l doses were selected). After a 2 89 i n c u b a t i o n in the m e d i u m containing the drug c o m b i n a t i o n , the retina was returned to control conditions, a n d recovery was m o n itored.
Results
Eight retinas perfused at 4.6 ml/min in control medium that was equilibrated with 40% 02 consumed a mean of 0.121 + 0.006 (standard error of the mean, SEM)/,moles of O2 per minute and generated 0.149 _+ 0.006 ~M of lactic acid. The retinas' energy metabolism responded as expected to physiological stimuli. Flashing light (4 Hz), which activates on-off responses of the inner retina, increased glycolysis with little change in oxidative metabolism; and steady light, which diminishes the energy-consuming "dark current" of the photoreceptors, decreased 02 consumption with little change in glycolysis. 4 Moderate reductions in the 02 content of the medium were associated with reversible reductions in 02 consumption and increases in glycolysis (Pasteur effect).
The changes in 02 consumption, glycolysis, and ERG B waves in response to a variety of agents are shown in 
Agents Causing Reversible Reduction in 02 Consumption and Glycolysis
The agents that were effective in reversibly reducing metabolism and electrophysiological function are shown in Fig. 3 . These agents had a rapid onset of action, with a half-life (~) for reduction of the b-wave of less than 2 minutes, and often less than 1 minute (see Fig. 2B ). The time course for reduction of 02 consumption was slower, with a ta in the range of 2 to 5 minutes. This, along with the ge~nerally quite prompt recovery after washout of the agents, serves as evidence that it x~ as the usage of energy, rather than its generation, that was reduced by these agents.
Hypothermia. Hypothermia caused quite parallel reductions in 02 consumption, glycolysis, and b-wave. Regression analyses of measurements obtained between 28* and 38"C showed a mean rate change with 10*C increase (Qm) of 1.9 ___ 0.1 for 02 consumption and 2.2 + 0.3 for glycolysis. The tissue responses occurred as fast as we could change the temperature and appeared to be completely reversible over this range.
Lithium. Lithium was administered as lithium sulfate or as lithium chloride. It caused consistent reductions in all of the parameters measured, and these were independent of the nature of the anion (Figs. 1 to 3 ). The responses of 02 consumption, glycolysis, and bwave were dose-related, at least to 16 mExt/liter of lithium, and were followed by full recovery on return to control medium. The ERG monitor (Fig. 2B) showed an initial b-wave recovery to greater than control amplitude, with subsequent return to the control level.
Strophanthidin. Strophanthidin caused a dose-related reduction in 02 consumption, to 50% at 1 gM, indicating that a major portion of the energy derived from oxidation is consumed by Na+K § triphosphatase (ATPase). The effect on glycolysis was less consistent at lower concentrations; but, in two experiments with 0.5 uM of strophanthidin (not shown in Fig. 3 ), glycolysis was reduced by 31% and 33%. Winkler 47 has reported a 61% reduction in glycolysis in rat retina treated with 100 uM of ouabain. At 0.5 uM and above, strophanthidin appeared to cause irreversible damage. At 0.25 and 0.15/~M, 02 consumption was still substantially reduced (by 28% and 24%, respectively), and this was promptly reversible. A dose of 0.1 ~M was used in the drug-combination experiment (see below), and this reduced 02 consumption by 7%.
Magnesium. Magnesium caused dose-related reductions of b-wave and glycolysis, with relatively tittle effect on 02 consumption. Although the effects of Mg ++ were quite reversible, recovery was relatively slow (~ = 14 minutes at 6 mM Mg++; U = 19 minutes at 20 mM Mg++), perhaps reflecting either the time required to transport excess Mg ++ out of the cells or some degree of toxicity. The combination of 6 mM of Mg ++ and 0.15 t~M of strophanthidin resulted in an additive effect on 02 consumption and glycolysis, both quite reversible. The electrophysiological response requires further study.
Phenytoin. Phenytoin (Dilantin) also caused substantial reductions in glycolysis and b-wave along with a modest reduction in 02 consumption. There was complete recovery of metabolism and partial recovery of the ERG (at lower doses, ERG recovery improved). A dose of 1.1 mM (300 mg/kg) caused no further reduction in 02 consumption and only minimal further decreases in glycolysis and b-wave (not shown in Fig.  3 ). This finding correlates with a protection study 5 which found that phenytoin significantly prolonged survival time in hypoxic mice at an optimal dose of 200 mg/kg, but not at 300 mg/kg.
Chlordiazepoxide. Chlordiazepoxide (Librium) at 200 uM consistently reduced glycolysis, 02 consumption, and the ERG b-wave, with full recovery. A dose of 300 tzM produced no significant further reduction in metabolism or b-wave (not shown in Fig. 3) .
Carbon Dioxide. Carbon dioxide caused a marked and very rapid reduction in b-wave, which recovered immediately when the CO2 of the medium was returned to normal levels, and it reduced 02 consumption by more than one-third. The concentration of CO2 in these experiments reduced the pH of the medium to 6.7, preventing an accurate measurement of glycolysis on the basis of its pH effects. Higher levels of CO2 caused irreversible changes, presumably due to the reductions in pH both intracellularly and extracelhilarly.
Amiloride. Amiloride produced substantial reductions in 02 consumption and glycolysis, with a slightly lesser effect on the ERG b-wave. However, recovery of these functions was quite delayed (U = 20 minutes for b-wave recovery).
Dantrolene. Dantrolene, which posed a solubility problem in our in vitro system, caused modest reductions in metabolic and electrophysiological parameters, with good recovery.
Agents That Were Not Reversible
Some of the agents studied were not reversible. These are shown in Fig. 4 .
Diphenhydramine. Diphenhydramine (Benadryl) in large doses (100 and 200 uM) caused a prompt and dramatic reduction in the b-wave, with nearly a 30% reduction in glycolysis and a lesser effect on 02 consumption. The metabolic functions recovered quite well, but a lower dose may be needed to allow full recovery of electrophysiological function.
Midazolam. Midazolam, a newer benzodiazepine now used clinically in anesthesia, produced reductions E. L. Zager and A. Ames III in Oz consumption and b-wave comparable to those seen with chlordiazepoxide, but did not reduce glycolysis or allow full recovery of the b-wave.
Nifedipine and Nimodipine. Nifedipine and nimodipine both appeared to reduce glycolysis selectively, with essentially no effect on 02 consumption. The ERG b-wave did not return to control levels after washout of these agents.
Quercetin. Quercetin significantly reduced 02 consumption, glycolysis, and the ERG b-wave, but recovery was poor in all functions, most likely due to the difficulty of removing the drug from the tissue.
Trial of Drugs in Combination
Based upon the above results with individual agents, a combination of six agents was selected in order to determine whether their effects were additive and still reversible after a prolonged exposure period. Figures 5  and 6 demonstrate that the agents in combination did have additive effects on 02 consumption. Phenytoin and chlordiazepoxide appeared to have synergistic effects in reducing both 02 consumption and glycolysis, with additional effects demonstrated by the subsequent agents. A lower dose of CO2 (15%) was used in the drug-combination experiment. The ERG b-wave was eliminated by the addition of the second drug, and the metabolic parameters were reduced to approximately 50% of the control levels. Reversibility was quite good after a 2 89 exposure to all six agents. Tables 1 and 2 list a variety of agents with known clinical effects on the CNS (for instance, general anesthetic, sedative, CNS depressant, and anticonvulsant drugs) or putative roles in altering cell membrane or receptor function. Each agent was administered in successive doses to a single retina. The data reported in these tables are responses to the highest doses given, with the exceptions of thiopental and ethanol; higher doses of these latter agents caused negligible further changes in metabolism.
Agents With Marginal or No Effects on Energy Metabolism

Discussion
Protecting CNS tissue against ischemia by reducing its energy requirements depends upon inhibiting metabolic processes that are not essential for maintaining cell viability, while preserving those that are. Astrup 6 has distinguished between "activation metabolism" (which supports signaling function) and "residual metabolism" (which supports the general "housekeeping" functions of the cells such as maintenance of membranes, ion transport, and synthesis of cellular components). An ideal protective agent would relieve the cell of its signaling workload while preserving the metabolic processes essential for viability. In addition, this hypothetical ideal agent would be quicMy and easily delivered to the CNS, and would have effects that are readily T h e screening system we have described here p e r m i t s the identification o f agents that reversibly reduce 02 c o n s u m p t i o n a n d glycolysis o f isolated o r g a n i z e d C N S tissue. O u r results d e m o n s t r a t e substantial differences in the tissue's response to various agents; there were dramatic and reversible reductions in energy metabolism and electrophysiological function in the presence of a few agents (phenytoin, chlordiazepoxide, and lithium), whereas surprisingly little effect was seen with several of the general CNS depressants (thiopental, Althesin, chlorpromazine, paraldehyde, and lidocaine).
Hypothermia has been recognized as an effective means of protection for some years. 33 Severe reductions in temperature can produce harmful effects on cells; 22 therefore, it is important to recognize that mild hypothermia, as demonstrated here, can substantially reduce metabolic demand. Hypothermia generally reduces the rates of most enzymatic reactions. However, the "membrane-stabilizing" effect of temperature reduction may also be important in its protective role. 6 Lithium has been the drug of choice in the treatment of manic-depressive illness for some time, despite the fact that its mechanism of action remains unclear. Its interaction with m e m b r a n e transport systems has been extensively investigated. Ehrlich and D i a m o n d ~7 reviewed these p h e n o m e n a in their paper published in 1980. More recently, it has been shown that lithium inhibits the enzyme inositol 1-phosphatase, thus preventing the regeneration of inositol. It has been proposed that lithium may exert its therapeutic effect by thus interfering with the metabolism of phosphoinositides, which m a y play a role in synaptic and receptor function. 9'4~ The reductions in energy metabolism and electrophysiological function measured in the retina, even at a therapeutic dose of 1 mM, make this an agent of considerable interest for ischemia studies.
A marked inhibition of Na+K+-ATPase by strophanthidin or other cardiac glycosides is in itself damaging to the cells. However, the data presented here suggest that partial inhibition (for instance, 20%) can be reversibly sustained and even permit continued electrophysiological function, with an appreciable saving of energy. There is previously published evidence that inhibition of this ATPase by ouabain reduces in vivo metabolism by 20% to 25% in dog brain 8 and m a y be protective against ischemic injury in other actively pumping tissues such as the kidney. 12. 13 Magnesium offers promise as a generalized inhibitor of synaptic transmission and of the accompanying energy expenditures. The marked and relatively selective reduction in the generation of lactic acid that was observed with Mg + § may itself be protective. 31 Magnesium crosses the blood-brain barrier slowly, 28 but large increases in plasma levels m a y have central depressant effects) ~ In recent studies of ischemia in the rabbit spinal cord, 32'46 Mg §247 pretreatment improved neurological outcome; however, at least in the latter study, 46 its effect was not likely due to inhibition of synaptic transmission in that it did not suppress somatosensory evoked potentials. Thus, it m a y have been effective via a vascular mechanism, such as enhancement of collateral circulation or prevention of delayed postischemic hypoperfusion. Phenytoin (Dilantin) is widely used clinically for its potent anticonvulsant activity. In animal studies it has been found to substantially prolong survival time in hypoxic mice S and to protect neurons in the hippocampus and dentate nucleus of rabbits subjected to 15 minutes of global cerebral ischemia. 15 Proposed mechanisms for this protective effect have included reduction of hypoxia-induced seizure activity, an increase in cerebral blood flow, and a reduction in the cerebral metabolic rate for 02; the former study, 5 which examined these proposals, did not find evidence to support any of them. These investigators did find that pretreatment with phenytoin resulted in a reduction in the rate of K + accumulation in cisternal CSF of dogs after 20 minutes of anoxia. Thus, a membrane-stabilizing role was proposed for phenytoin's mode of action. In accord with our finding of a predominant effect on glycolysis, an earlier study reported that phenytoin pretreatment (200 mg/kg) resulted in a reduction in the utilization of glucose and high-energy phosphate in mouse brain after decapitation. J4
Chlordiazepoxide (Librium) and midazolam are benzodiazepines that are clinically useful for treatment of alcohol withdrawal, as anxiolytic and sedative-hypnotic agents, and for induction of general anesthesia. Midazolam and another benzodiazepine, diazepam (Valium), have been found to reduce the cerebral metabolic rate for O2 in the dog, and to provide significant protection in a hypoxic mouse model. 25 Even at the extremely high doses of chlordiazepoxide in our model, the retinas recovered promptly and completely all parameters of metabolic and electrophysiological function. This, along with this agent's wide margin of clinical safety,~9 make chlordiazepoxide a promising agent for further study.
The rather high levels of CO2 examined caused a surprisingly large reduction in O2 consumption; this effect was not observed with a similar CO2 concentration in rat brain in vivo. 23 The latter study did demonstrate a significant reduction in glucose utilization, an effect probably seen in our system as well, although we were unable to measure this accurately at the higher CO2 levels. In a protection study, Secher and Wilhjelm 39 found that a concentration of 5 % CO2 in the inhaledgas mixture increased survival time of anoxic mice by 137%. These findings, together with the rapidity with which electrophysiological function recovered after elevated CO2 in our system, suggest that this agent warrants further investigation, even though its effects on the cerebral vasculature will have to be taken into account.
2-Amino-5-phosphonovaleric acid (APV) is a potent representative of a new class of agents that inhibit excitotoxic amino acid receptors? 8 There is some evidence that synaptic release of these excitatory amino acid neurotransmitters (glutamate and aspartate) may contribute to neuronal death due to hypoxia. 34"35 Two of the receptor blockers (2-amino-7-phosphonoheptanoic acid and 3,-D-glutamylglycine) have been shown to protect against ischemic neuronal damage in rat brain in vivo 41 and in vitro. 34 Amiloride is a K+-sparing diuretic that blocks the Na + channel in the distal nephron, z7 This Na + channel is apparently characteristic of "tight" epithelia 16 and is probably also present in the CNS. 36 Dantrolene is used clinically as an effective antispasticity agent, and is the treatment of choice for malignant hyperthermia. It reduces contraction of skeletal muscle by a direct action on excitation-contraction coupling, perhaps by decreasing the amount of calcium released from the sarcoplasmic reticulum. ~9 An uncontrolled increase in intracellular calcium is thought to be one of the important pathophysiological events during ischemia. Thus, a logical drug combination for treatment of ischemia might include dantrolene to inhibit release of intracellularly sequestered calcium and nifedipine or nimodipine to block entry of extracellular calcium. Nimodipine administration has resulted in improved neurological outcomes after complete cerebral ischemia in dogs when given prior to ischemia 4~ and in primates when given 5 minutes after an ischemic episode. 43 In mongolian gerbils, pretreatment with nimodipine retarded the fall in adenosine triphosphate in cortex and striatum during ischemia and facilitated the recovery of glucose in these regions during recirculation. 2~ The beneficial results found with nimodipine in ischemia studies and in patients with vasospasm after subarachnoid hemorrhage 2 may be secondary to its metabolic as well as its vascular effects.
Several other agents depicted in Fig. 4 are of potential interest. Histamine is currently considered a likely candidate as a neurotransmitter in mammalian brain. 38 H 1 and H2 histamine receptors, as well as other subtypes, are believed to reside in the CNS, and these may mediate the well-known sedative effects of the clinically useful antihistamines. 37 Thus, it is not altogether surprising that diphenhydramine (Benadryl) had pronounced effects upon CNS tissue metabolism and electrophysiological responses in our model. It is also of interest that, at high doses, H l receptor antagonists like diphenhydramine have a local anesthetic action. The poor reversibility of the ERG b-wave after removal of this drug may indicate a problem with toxicity in neurons. Quercetin is a ubiquitous plant flavonoid with a wide variety of postulated physiological effects. Of particular interest is a proposal that quercetin may enhance the efficiency of Na+K+-ATPase. 3~ The reductions in energy metabolism that we observed in the retina may correlate with this hypothesis. The irreversibility of its effects is probably attributable to difficulty in eluting the drug with our protein-free medium. 3~
Our results for the agents listed in Tables 1 and 2 indicate surprisingly little reduction in energy metabolism by these CNS depressants. This is in contrast with studies on intact brain which have shown significant reductions in metabolic rate in response to some of these agents. 6"7"21 This may reflect a greater effect of these anesthetic agents on highly integrated systems containing many synapses in sequence. The literature on barbiturates and CNS protection is divided; there seem to be protective effects in focal cerebral ischemia, ~' 26"42 but not consistently in global ischemia. TM Lidocaine did not protect against ischemia in rabbit spinal cord. 32 The classification of the agents used in our study into the various categories illustrated in the figures and tables is somewhat arbitrary. For example, valproic acid was categorized as an agent that had marginal effects on energy metabolism. It did appear to reduce both oxygen consumption and glycolysis, but less dramatically than did the agents in Fig. 3 . Other agents (such as Althesin, ethanol, thiopental, ether, scopolamine, lidocaine, and gamma-hydroxybutyric acid) appeared to reduce glycolysis selectively, with generally fair to good reversibility. Certain of these agents may well deserve further consideration in protection studies, in which a small but reproducible energy savings could contribute to recovery in marginally perfused tissue. In particular, the agents that reduced glycolysis selectively may be useful in combination with agents that reduced oxygen consumption primarily.
The single trial in which the retina was exposed to both Mg § and strophanthidin represents a preliminary demonstration that agents with different mechanisms of action can be usefully combined. The experiment in which the retina was exposed simultaneously to six agents (each of which individually reduced energy metabolism) demonstrated that CNS tissue can tolerate a prolonged period of reduction of 02 consumption and glycolysis to less than 50% of control levels with essentially full recovery of both metabolic and electrophysiological function. We plan further combination experiments such as this, including combinations with mild hypothermia. Vacanti and Ames 46 reported that the rabbit spinal cord stroke model has demonstrated the efficacy of combination therapy with elevated serum Mg + § and mild hypothermia. Other animal models and combinations of agents have been tried as well. 7
